The FDA approved the first pill for postpartum depression on Friday. The drug is called zuranolone, and unlike other antidepressants, it's specifically designated for postpartum depression, a condition that affects around 1 in 7 new mothers.
The big picture: Zuranolone is taken daily for two weeks. Clinical trials showed that the drug could ease depression in as little as three days.
Guests: Axios' Felix Salmon, Arielle Dreher and Marina Franco.
Credits: Axios Today is produced by Erica Pandey, Alexandra Botti, Fonda Mwangi, Robin Linn and Alex Sugiura. Music is composed by Evan Viola. You can reach us at podcasts@axios.com. You can text questions, comments and story ideas to Niala as a text or voice memo to 202-918-4893.
Activity